Source: MyPhenome genetic obesity test
What You Should Know:
– Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
– The research will evaluate…
Continue Reading
Background: Maintaining accurate medication records in clinical trials is essential to ensure data validity. Traditional methods such as direct observation, self-reporting, and pill counts have shown limitations that make them inaccurate or impractical. Video-based…
Continue Reading
What You Should Know:
– Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in…
Continue Reading
Rajneesh Patil Vice President, Digital Innovation at IQVIA
Nicholas Whitney, Senior Director, Site Suite, IQVIA Technologies
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.Unlearn, founded in 2017, uses…
Continue Reading
Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study…
Continue Reading
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading
Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To…
Continue Reading
Healthtech company Flatiron Health is collaborating with NRG Oncology, a clinical research consortium in the National Cancer Institute’s National Clinical Trials Network with more than 1,300 worldwide research sites, to deploy Flatiron Clinical Pipe…
Continue Reading
What You Should Know:
– Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute’s (NCI)…
Continue Reading
